"BARDA Broad Agency Announcement for Advanced Research and Development of Medical Countermeasures for Pandemic Influenza
Added: Apr 05, 2011 3:27 pm The pre solicitation notice for BAA-BARDA-11-100-SOL-00013 is hereby canceled until further notice. Please continue to monitor www.fbo.gov for any subsequent updates."
The above was announced 4 days after BARDA announcing its grant to BTA on 1st April.
Surely the BARDA blow torch is now on BTA to progress the milestones for its grant. Inavir is the only influenza anti viral candidate for Phase 111 in US, apart from BCRX (IV For Hospitalised cases).
Should we be hearing news shortly on the manufacturing side of the grant - the first cab off the rank in the grant outcomes ?
BTA Price at posting:
$1.20 Sentiment: Hold Disclosure: Held
